Delivery Order SPE2DB20D2014-SPE2DB25FC69B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Metoprolol Succinate Extended Release 50 mg, valued at $1,312.12. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The products will be delivered to Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,182.44 for 1,000 tablets of Metoprolol Succinate Extended-Release 25 mg, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $4,155.00 to AmerisourceBergen Drug Corp for 1,000 tablets of Metoprolol Succinate Extended-Release 50 mg, with an ultimate completion date of July 28, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through...
- This federal contract award, valued at $1,098.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,076,308 units of Metoprolol Succinate Extended-Release 100 mg Tablets. The contract has a performance period extending through April 30, 2025 and is priced on a firm-fixed-price basis. AmerisourceBergen Drug Corp holds a significant...
- This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of 4,560,483,611 units of Metoprolol Succinate Extended-Release 100 mg tablets in quantities of 1,000 units per bottle. The contract, valued at $1,979.28, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of April 5, 2023. The contract does not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,743.51 firm fixed-price delivery order is for the supply of 4,559,461,647 units of Metoprolol Succinate ER 25 mg tablets. The award has an ultimate completion date of December 29, 2022 and was made on December 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB22FN7D3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,899.56 delivery order is for the supply of Metoprolol Succinate ER 50 mg tablets in 1,000-count packages. The contract has a firm fixed price and an ultimate completion date of May 24, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award is for the delivery of Metoprolol Succinate Extended-Release 25mg tablets in 1,000-count bottles to the Defense Logistics Agency (DLA). The $6,335.98 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 23, 2022 with a completion date of September 26, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Metoprolol Succinate Extended-Release 50mg tablets in 1,000 count packages. The $1,938.50 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC serves as the primary vehicle for...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC69BDelivery Order
The Defense Logistics Agency awarded a $4,989.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of 1,000 tablets of Metoprolol Succinate ER 100 mg. The contract is scheduled for ultimate completion on August 8, 2025, and represents a non-set-aside competitive award. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The work will be performed at the company's corporate office in Conshohocken, PA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/7/25 |